TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
VSee Health ( (VSEE) ) has issued an announcement.
On September 2, 2025, VSee Health received a notification from Nasdaq indicating non-compliance with the equity rule due to a stockholders’ deficit. Following an appeal and a hearing on September 9, 2025, the Nasdaq Hearings Panel granted VSee Health an exception to complete its compliance plan. The company has since undertaken various transactions, including warrant exercises and stock conversions, to meet the equity rule requirements. A pro forma balance sheet, assuming these transactions closed by December 31, 2025, shows compliance with the equity rule, with total stockholders’ equity of $13.2 million.
The most recent analyst rating on (VSEE) stock is a Sell with a $0.51 price target. To see the full list of analyst forecasts on VSee Health stock, see the VSEE Stock Forecast page.
Spark’s Take on VSEE Stock
According to Spark, TipRanks’ AI Analyst, VSEE is a Underperform.
VSee Health’s overall stock score is heavily impacted by its poor financial performance and weak valuation metrics. The company’s negative equity and unprofitability are significant red flags. Technical analysis indicates bearish momentum, further weighing down the score. The absence of earnings call data and corporate events means these factors do not influence the score.
To see Spark’s full report on VSEE stock, click here.
More about VSee Health
Average Trading Volume: 13,362,458
Technical Sentiment Signal: Sell
Current Market Cap: $16.93M
For an in-depth examination of VSEE stock, go to TipRanks’ Overview page.